Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with ...

A home blood pressure telemonitoring (HBPT) program effectively reduced BP in real-world clinical settings, but its enrollment expenses increased overall costs. The HBPT program reduced BP clinic ...

VANCOUVER, BC / ACCESS Newswire / March 16, 2026 / Gamma Resources Ltd. (TSXV:GAMA)(OTCQB:GAMXF)(FRA:MRDN) ("Gamma" or the "Company") is pleased that it has engaged SWCA Environmental Consultants ("SW ...

Despite a pressing need to improve outcomes and address inequities in nursing homes, there is limited evidence about the specific factors required to successfully implement real-world interventions in ...

Medical University of South Carolina researchers report in Palliative and Supportive Care that early virtual palliative care for people living with dementia, as well as for their caregivers, is both ...

Cost overruns and schedule delays across the nuclear weapons management agency's $30B construction portfolio have more than doubled since 2023.

Mave Health is listing the headset at $495 for pre-orders. It aims to ship devices to users in the U.S. and India in April ...

Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC - an emerging PD biomarker) at baseline ...

Welcome to Brii Bio's 2025 Full Year Financial Results and Corporate Update Conference Call. Our annual result announcements can be found on the Investor Relations section of our company website.

STELLAR-2, a randomized, double-blind, sham-controlled study, will evaluate the effects of salanersen when initiated ~6 ...

G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...

Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 -- -- Interim systemic lung cancer data with Olvi-Vec demonstrated partial responses in ...